{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T20:40:30Z","timestamp":1772829630096,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,12,8]],"date-time":"2015-12-08T00:00:00Z","timestamp":1449532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,12,8]],"date-time":"2015-12-08T00:00:00Z","timestamp":1449532800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Data"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Non-alcoholic fatty liver disease (NAFLD) is a consequence of sedentary life style and high fat diets with an estimated prevalence of about 30% in western countries. It is associated with insulin resistance, obesity, glucose intolerance and drug toxicity. Additionally, polymorphisms within, e.g., <jats:italic>APOC3, PNPLA3, NCAN, TM6SF2<\/jats:italic> and <jats:italic>PPP1R3B<\/jats:italic>, correlate with NAFLD. Several studies have already investigated later stages of the disease. This study explores the early steatosis stage of NAFLD with the aim of identifying molecular mechanisms underlying the etiology of NAFLD. We analyzed liver biopsies and serum samples from patients with high- and low-grade steatosis (also pre-disease states) employing transcriptomics, ELISA-based serum protein analyses and metabolomics. Here, we provide a detailed description of the various related datasets produced in the course of this study. These datasets may help other researchers find new clues for the etiology of NAFLD and the mechanisms underlying its progression to more severe disease states.<\/jats:p>","DOI":"10.1038\/sdata.2015.68","type":"journal-article","created":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T17:24:55Z","timestamp":1449509095000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Multi-omic profiles of human non-alcoholic fatty liver disease tissue highlight heterogenic phenotypes"],"prefix":"10.1038","volume":"2","author":[{"given":"Wasco","family":"Wruck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karl","family":"Kashofer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samrina","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andriani","family":"Daskalaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Berg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewa","family":"Gralka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justyna","family":"Jozefczuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharina","family":"Drews","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vikash","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Regenbrecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Wierling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Turano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrike","family":"Korf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kurt","family":"Zatloukal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"Lehrach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans V.","family":"Westerhoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Adjaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,12,8]]},"reference":[{"key":"BFsdata201568_CR1","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1055\/s-0028-1091978","volume":"28","author":"M Lazo","year":"2008","unstructured":"Lazo, M. & Clark, J. M. The epidemiology of nonalcoholic fatty liver disease: a global perspective. Semin. Liver Dis. 28, 339\u2013350 (2008).","journal-title":"Semin. Liver Dis."},{"key":"BFsdata201568_CR2","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1056\/NEJMoa0907295","volume":"362","author":"KF Petersen","year":"2010","unstructured":"Petersen, K. F. et al. Apolipoprotein C3 Gene Variants in Nonalcoholic Fatty Liver Disease. N. Engl. J. Med. 362, 1082\u20131089 (2010).","journal-title":"N. Engl. J. Med."},{"key":"BFsdata201568_CR3","doi-asserted-by":"publisher","first-page":"e1001324","DOI":"10.1371\/journal.pgen.1001324","volume":"7","author":"EK Speliotes","year":"2011","unstructured":"Speliotes, E. K. et al. Genome-Wide Association Analysis Identifies Variants Associated with Nonalcoholic Fatty Liver Disease That Have Distinct Effects on Metabolic Traits. PLoS Genet 7, e1001324 (2011).","journal-title":"PLoS Genet"},{"key":"BFsdata201568_CR4","doi-asserted-by":"publisher","first-page":"e36320","DOI":"10.1371\/journal.pone.0036320","volume":"7","author":"D Samocha-Bonet","year":"2012","unstructured":"Samocha-Bonet, D. et al. Overfeeding Reduces Insulin Sensitivity and Increases Oxidative Stress, without Altering Markers of Mitochondrial Content and Function in Humans. PLoS ONE 7, e36320 (2012).","journal-title":"PLoS ONE"},{"key":"BFsdata201568_CR5","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.jhep.2010.04.008","volume":"53","author":"V Ratziu","year":"2010","unstructured":"Ratziu, V., Bellentani, S., Cortez-Pinto, H., Day, C. & Marchesini, G. A position statement on NAFLD\/NASH based on the EASL 2009 special conference. J. Hepatol. 53, 372\u2013384 (2010).","journal-title":"J. Hepatol."},{"key":"BFsdata201568_CR6","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.cmet.2012.03.004","volume":"15","author":"RV Farese Jr.","year":"2012","unstructured":"Farese, R. V. Jr., Zechner, R., Newgard, C. B. & Walther, T. C. The Problem of Establishing Relationships between Hepatic Steatosis and Hepatic Insulin Resistance. Cell Metab. 15, 570\u2013573 (2012).","journal-title":"Cell Metab."},{"key":"BFsdata201568_CR7","doi-asserted-by":"publisher","first-page":"32345","DOI":"10.1074\/jbc.M313478200","volume":"279","author":"VT Samuel","year":"2004","unstructured":"Samuel, V. T. et al. Mechanism of Hepatic Insulin Resistance in Non-alcoholic Fatty Liver Disease. J. Biol. Chem. 279, 32345\u201332353 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFsdata201568_CR8","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.2337\/db11-1488","volume":"61","author":"SN Rajpathak","year":"2012","unstructured":"Rajpathak, S. N. et al. Insulin-like growth factor axis and risk of type 2 diabetes in women. Diabetes 61, 2248\u20132254 (2012).","journal-title":"Diabetes"},{"key":"BFsdata201568_CR9","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1530\/EJE-09-0374","volume":"161","author":"H V\u00f6lzke","year":"2009","unstructured":"V\u00f6lzke, H. et al. Association between hepatic steatosis and serum IGF1 and IGFBP-3 levels in a population-based sample. Eur. J. Endocrinol. 161, 705\u2013713 (2009).","journal-title":"Eur. J. Endocrinol."},{"key":"BFsdata201568_CR10","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1177\/0192623310396905","volume":"39","author":"E Aleem","year":"2011","unstructured":"Aleem, E., Nehrbass, D., Klimek, F., Mayer, D. & Bannasch, P. Upregulation of the insulin receptor and type I insulin-like growth factor receptor are early events in hepatocarcinogenesis. Toxicol. Pathol. 39, 524\u2013543 (2011).","journal-title":"Toxicol. Pathol."},{"key":"BFsdata201568_CR11","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1016\/j.jhep.2011.10.027","volume":"56","author":"G Baffy","year":"2012","unstructured":"Baffy, G., Brunt, E. M. & Caldwell, S. H. Hepatocellular carcinoma in non-alcoholic fatty liver disease: An emerging menace. J. Hepatol. 56, 1384\u20131391 (2012).","journal-title":"J. Hepatol."},{"key":"BFsdata201568_CR12","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.molmed.2007.12.003","volume":"14","author":"F Marra","year":"2008","unstructured":"Marra, F., Gastaldelli, A., Svegliati Baroni, G., Tell, G. & Tiribelli, C. Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis. Trends Mol. Med. 14, 72\u201381 (2008).","journal-title":"Trends Mol. Med."},{"key":"BFsdata201568_CR13","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1056\/NEJMra011775","volume":"346","author":"P Angulo","year":"2002","unstructured":"Angulo, P. Nonalcoholic fatty liver disease. N. Engl. J. Med. 346, 1221\u20131231 (2002).","journal-title":"N. Engl. J. Med."},{"key":"BFsdata201568_CR14","doi-asserted-by":"publisher","first-page":"339","DOI":"10.3389\/fphys.2012.00339","volume":"3","author":"J Jozefczuk","year":"2012","unstructured":"Jozefczuk, J. et al. A Systems Biology Approach to Deciphering the Etiology of Steatosis Employing Patient-Derived Dermal Fibroblasts and iPS Cells. Front. Physiol 3, 339 (2012).","journal-title":"Front. Physiol"},{"key":"BFsdata201568_CR15","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1038\/nature04634","volume":"440","author":"N Houstis","year":"2006","unstructured":"Houstis, N., Rosen, E. D. & Lander, E. S. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 440, 944\u2013948 (2006).","journal-title":"Nature"},{"key":"BFsdata201568_CR16","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1038\/oby.2011.298","volume":"19","author":"HM Findeisen","year":"2011","unstructured":"Findeisen, H. M. et al. Glutathione Depletion Prevents Diet-Induced Obesity and Enhances Insulin Sensitivity. Obesity 19, 2429\u20132432 (2011).","journal-title":"Obesity"},{"key":"BFsdata201568_CR17","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1146\/annurev.pharmtox.45.120403.095857","volume":"45","author":"JD Hayes","year":"2005","unstructured":"Hayes, J. D., Flanagan, J. U. & Jowsey, I. R. Glutathione Transferases. Annu. Rev. Pharmacol. Toxicol. 45, 51\u201388 (2005).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"BFsdata201568_CR18","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/hep.26661","volume":"59","author":"CA Moylan","year":"2014","unstructured":"Moylan, C. A. et al. Hepatic gene expression profiles differentiate presymptomatic patients with mild versus severe nonalcoholic fatty liver disease. Hepatol. Baltim. Md 59, 471\u2013482 (2014).","journal-title":"Hepatol. Baltim. Md"},{"key":"BFsdata201568_CR19","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1053\/j.gastro.2015.01.038","volume":"148","author":"B Kahali","year":"2015","unstructured":"Kahali, B. et al. TM6SF2: catch-22 in the fight against nonalcoholic fatty liver disease and cardiovascular disease? Gastroenterology 148, 679\u2013684 (2015).","journal-title":"Gastroenterology"},{"key":"BFsdata201568_CR20","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1038\/ng.2901","volume":"46","author":"J Kozlitina","year":"2014","unstructured":"Kozlitina, J. et al. Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease. Nat. Genet. 46, 352\u2013356 (2014).","journal-title":"Nat. Genet."},{"key":"BFsdata201568_CR21","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nature14132","volume":"518","author":"D Shungin","year":"2015","unstructured":"Shungin, D. et al. New genetic loci link adipose and insulin biology to body fat distribution. Nature 518, 187\u2013196 (2015).","journal-title":"Nature"},{"key":"BFsdata201568_CR22","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1002\/hep.23050","volume":"50","author":"AE Feldstein","year":"2009","unstructured":"Feldstein, A. E. et al. Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: A multicenter validation study. Hepatology 50, 1072\u20131078 (2009).","journal-title":"Hepatology"},{"key":"BFsdata201568_CR23","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1053\/j.gastro.2015.05.044","volume":"149","author":"J Du Plessis","year":"2015","unstructured":"Du Plessis, J. et al. Association of Adipose Tissue Inflammation With Histologic Severity of Nonalcoholic Fatty Liver Disease. Gastroenterology 149, 635\u2013648, e14 (2015).","journal-title":"Gastroenterology"},{"key":"BFsdata201568_CR24","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews, D. R. et al. Homeostasis model assessment: insulin resistance and \u03b2-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412\u2013419 (1985).","journal-title":"Diabetologia"},{"key":"BFsdata201568_CR25","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner, D. E. et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41, 1313\u20131321 (2005).","journal-title":"Hepatology"},{"key":"BFsdata201568_CR26","doi-asserted-by":"publisher","first-page":"R80","DOI":"10.1186\/gb-2004-5-10-r80","volume":"5","author":"RC Gentleman","year":"2004","unstructured":"Gentleman, R. C. et al. Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 5, R80 (2004).","journal-title":"Genome Biol."},{"key":"BFsdata201568_CR27","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1093\/bioinformatics\/btn224","volume":"24","author":"P Du","year":"2008","unstructured":"Du, P., Kibbe, W. A. & Lin, S. M. lumi: a pipeline for processing Illumina microarray. Bioinformatics 24, 1547\u20131548 (2008).","journal-title":"Bioinformatics"},{"key":"BFsdata201568_CR28","doi-asserted-by":"crossref","unstructured":"Smyth, G. K. Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments. Stat. Appl. Genet. Mol. Biol. 3 doi:10.2202\/1544-6115.1027 (2004).","DOI":"10.2202\/1544-6115.1027"},{"key":"BFsdata201568_CR29","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1002\/hep.24097","volume":"53","author":"OT Ayonrinde","year":"2011","unstructured":"Ayonrinde, O. T. et al. Gender-specific differences in adipose distribution and adipocytokines influence adolescent nonalcoholic fatty liver disease. Hepatol. Baltim. Md 53, 800\u2013809 (2011).","journal-title":"Hepatol. Baltim. Md"},{"key":"BFsdata201568_CR30","author":"W. Wruck","year":"2014","unstructured":"Wruck, W. NCBI GEO GSE46300 (2014)"},{"key":"BFsdata201568_CR31","author":"W. Wruck","year":"2015","unstructured":"Wruck, W. MetaboLights MTBLS174 (2015)"},{"key":"BFsdata201568_CR32","doi-asserted-by":"publisher","DOI":"10.6084\/m9.figshare.1333564","author":"W. Wruck","year":"2015","unstructured":"Wruck, W. Figshare https:\/\/doi.org\/10.6084\/m9.figshare.1333564 (2015)"}],"container-title":["Scientific Data"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/sdata201568.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/sdata201568","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/sdata201568.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T12:58:24Z","timestamp":1672923504000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/sdata201568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,8]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,12,8]]}},"alternative-id":["BFsdata201568"],"URL":"https:\/\/doi.org\/10.1038\/sdata.2015.68","relation":{"references":[{"id-type":"uri","id":"http:\/\/www.ncbi.nlm.nih.gov\/geo\/query\/acc.cgi?acc=GSE46300","asserted-by":"subject"},{"id-type":"uri","id":"https:\/\/www.ebi.ac.uk\/metabolights\/MTBLS174","asserted-by":"subject"},{"id-type":"doi","id":"10.6084\/m9.figshare.1333564","asserted-by":"subject"}]},"ISSN":["2052-4463"],"issn-type":[{"value":"2052-4463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,8]]},"assertion":[{"value":"16 March 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"150068"}}